Search Results - "Berthold, D. R."

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa by Berthold, D.R., Pond, G.R., de Wit, R., Eisenberger, M., Tannock, I.F.

“…The TAX 327 study compared 3-weekly docetaxel, weekly docetaxel or 3-weekly mitoxantrone, each with prednisone, for 1006 patients with metastatic…”
Get full text

Renal cancer treatment in Spain: An online survey by Duran, I., Sanchez Maurino, P., Garcia-Donas, J., Berthold, D. R.

“…Abstract only 397 Background: Renal cancer incidence has increased in the last decades. Many treatment options have also been developed in this period…”
Get full text

The transition from phase II to phase III studies by Tannock, I., Gulamhusein, A., Berthold, D. R.

“…Abstract only 6514 Background: Phase II trials are performed to detect potential anti-tumor effects of a new treatment and should be used to decide whether to…”
Get full text

Cetuximab in combination with docetaxel in patients (pts) with metastatic castration resistant (mCRPC) and docetaxel-refractory prostate cancer: A multicenter phase II trial (SAKK 08/07) by Cathomas, R., Rothermundt, C., von Moos, R., Betticher, D. C., Winterhalder, R. C., Droege, C., Siciliano, D., Berthold, D. R., Pless, M., Gillessen, S.

“…Abstract only…”
Get full text

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) by Necchi, Andrea, Sonpavde, Guru, Lo Vullo, Salvatore, Giardiello, Daniele, Bamias, Aristotelis, Crabb, Simon J, Harshman, Lauren C, Bellmunt, Joaquim, De Giorgi, Ugo, Sternberg, Cora N, Cerbone, Linda, Ladoire, Sylvain, Wong, Yu-Ning, Yu, Evan Y, Chowdhury, Simon, Niegisch, Gunter, Srinivas, Sandy, Vaishampayan, Ulka N, Pal, Sumanta K, Agarwal, Neeraj, Alva, Ajjai, Baniel, Jack, Golshayan, Ali-Reza, Morales-Barrera, Rafael, Bowles, Daniel W, Milowsky, Matthew I, Theodore, Christine, Berthold, Dominik R, Daugaard, Gedske, Sridhar, Srikala S, Powles, Thomas, Rosenberg, Jonathan E, Galsky, Matthew D, Mariani, Luigi

“…Abstract Background The available prognostic models for overall survival (OS) in patients with metastatic urothelial carcinoma (UC) have been derived from…”
Get full text

Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma by Sonpavde, Guru P., Mariani, Luigi, Lo Vullo, Salvatore, Raggi, Daniele, Giannatempo, Patrizia, Bamias, Aristotle, Crabb, Simon J., Bellmunt, Joaquim, Yu, Evan Y., Niegisch, Guenter, Vaishampayan, Ulka N., Theodore, Christine, Berthold, Dominik R., Srinivas, Sandy, Sridhar, Srikala S., Plimack, Elizabeth R., Rosenberg, Jonathan E., Powles, Thomas, Galsky, Matthew D., Necchi, Andrea

“…We evaluated the impact of the number of cycles of platinum based, first line chemotherapy (fewer than 6 cycles vs the conventional 6 cycles or more) on the…”
Get full text

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival of the TAX 327 study by Berthold, D. R., Pond, G., DeWit, R., Eisenberger, M., Tannock, I. F.

“…Abstract only 5005 Background: The TAX-327 study compared 3 weekly docetaxel (D3), weekly docetaxel (D1) or mitoxantrone (M), each with prednisone (P) for 1006…”
Get full text

Sorafenib for the treatment of metastatic renal cancer (MRC) in the real world: The Princess Margaret Hospital (PMH) experience by Chin, S., Riechelmann, R. P., Wang, L., Tannock, I. F., Berthold, D. R., Moore, M., Knox, J. J.

“…Abstract only 15568 Background: Sorafenib, an oral multi-kinase inhibitor, prolonged progression free survival (PFS) of MRC patients (pts) in second line when…”
Get full text

Quality of life (QOL) of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) following treatment with docetaxel or mitoxantrone in the TAX-327 study by Pond, G. R., Berthold, D. R., Dewit, R., Eisenberger, M., Tannock, I. F.

“…Abstract only 4557 Background: The TAX-327 study compared 3-weekly docetaxel (D3), weekly docetaxel (D1) or mitoxantrone (M), each with prednisone (P) for 1006…”
Get full text

Association of pain and quality of life (QOL) response with PSA response and survival of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) treated with docetaxel or mitoxantrone in the TAX-327 study by Berthold, D. R., Pond, G., De Wit, R., Eisenberger, M. A., Tannock, I. F.

“…Abstract only 4516 Background: The TAX-327 study compared 3 weekly docetaxel (D3), weekly docetaxel (D1) or mitoxantrone (M), each with prednisone (P) for 1006…”
Get full text

Initial versus recent outcomes with a non–risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT) by Duran, I., Sturgeon, J. F., Jewett, M. A., Anson-Cartwright, L., Berthold, D. R., Kakiashvili, D., Warde, P. R., Alison, R. E., Pond, G. R., Moore, M. J.

“…Abstract only 5021 Background: Since 1981 the Princess Margaret Hospital testicular cancer group has used surveillance as the preferred management option for…”
Get full text

Management of Advanced Prostate Cancer After First-Line Chemotherapy by BERTHOLD, Dominik R, STERNBERG, Cora N, TANNOCK, Ian F

“…Hormone refractory prostate cancer (HRPC) causes substantial morbidity and mortality. There are increasing options for both first- and second-line therapy in…”
Get full text

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis by Necchi, Andrea, Mariani, Luigi, Lo Vullo, Salvatore, Yu, Evan Y, Woods, Michael E, Wong, Yu-Ning, Harshman, Lauren C, Alva, Ajjaj, Sternberg, Cora N, Bamias, Aristotelis, Grivas, Petros, Koshkin, Vadim S, Roghmann, Florian, Dobruch, Jakub, Eigl, Bernie J, Nappi, Lucia, Milowsky, Matthew I, Niegisch, Guenter, Pal, Sumanta K, De Giorgi, Ugo, Recine, Federica, Vaishampayan, Ulka, Berthold, Dominik D, Bowles, Daniel W, Baniel, Jack, Theodore, Christine, Ladoire, Sylvain, Srinivas, Sandy, Agarwal, Neeraj, Crabb, Simon, Sridhar, Srikala, Golshayan, Ali-Reza, Ohlmann, Carsten, Xylinas, Evanguelos, Powles, Thomas, Rosenberg, Johnathan E, Bellmunt, Joaquim, van Rhijn, Bas, Galsky, Matthew D, Hendricksen, Kees

“…Abstract Background Limited data is available on the role, and extent of, postchemotherapy lymphadenectomy (PC-LND) in patients with clinical evidence of…”
Get full text

Active surveillance for early-stage prostate cancer by Jichlinski, P, Berthold, D R, Zouhair, A, Griesser, A-C, Meuwly, J-Y, Prior, J O, Lhermitte, B, Doerfler, A, Treuthardt, C, Praz, V, Tawadros, T, Vaucher, L, Aymon, D, Marazzi, A, Levi, F, Beckmann, J, Leyvraz, S, Bauer, J

“…Diagnostic and treatment management of prostate cancer at its initial stage continues to raise important debates within the involved medical community. To…”
Get more information

Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study by Necchi, Andrea, Pond, Gregory R, Smaldone, Marc C, Pal, Sumanta K, Chan, Kevin, Wong, Yu-Ning, Viterbo, Rosalia, Sonpavde, Guru, Harshman, Lauren C, Crabb, Simon, Alva, Ajjai, Chowdhury, Simon, De Giorgi, Ugo, Srinivas, Sandy, Agarwal, Neeraj, Bamias, Aristotelis, Baniel, Jack, Golshayan, Ali-Reza, Ladoire, Sylvain, Sternberg, Cora N, Cerbone, Linda, Yu, Evan Y, Bellmunt, Joaquim, Vaishampayan, Ulka, Niegisch, Gunter, Hussain, Syed, Bowles, Daniel W, Morales-Barrera, Rafael, Milowsky, Matthew I, Theodore, Christine, Berthold, Dominik R, Sridhar, Srikala S, Powles, Thomas, Rosenberg, Jonathan E, Galsky, Matthew D

“…Abstract Background Little is known about the outcomes of robot-assisted radical cystectomy (RARC) compared to open radical cystectomy (ORC) combined with…”
Get full text

Early prognostic screening for posttraumatic stress disorder with the Davidson Trauma Scale and the SPAN by Sijbrandij, Marit, Olff, Miranda, Opmeer, Brent C., Carlier, Ingrid V.E., Gersons, Berthold P.R.

“…Background: This study examined the accuracy of the 17‐item Dutch version of the Davidson Trauma Scale (DTS) and the four‐item SPAN (Startle, Physiological…”
Get full text

Are prostate cancer clinical trial enrollment criteria and endpoints appropriate? by Tannock, Ian F, Berthold, Dominik R

Get full text

CHINESE PIGEON WHISTLES by BY DR. BERTHOLD LAUFER, COLUMBIA UNIVERSITY

“…Traditions imbided in school, through education and by reading, are apt to sway our lives and our thoughts, and to influence strongly our judgment of other…”
Get full text